Company-wide revenue
Reported revenue in 2020 ¥8.94B Reported revenue in 2024 ¥4.85B
- growth amount
- −¥4.09B
- growth annualized
- -14.2%
- growth total
- -45.8%
Japanese company profile · 2385
Soiken Holdings Inc.
In its FY2024 public filing, Soiken Holdings Inc. reports Biometrics, Healthcare support, Cosmetics, Health supplements, and 1 other reported businesses. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 株式会社総医研ホールディングス
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
Soiken Holdings Inc.'s largest reported business by revenue in FY2024 was Health supplements.
The business with the highest reported segment profit in FY2024 was Healthcare support.
FY2024 · fiscal year ended June 2025 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Health supplements | ¥2.14B ↗ | 44.1% | ¥91.21M ↗ |
| Cosmetics | ¥1.51B ↗ | 31.1% | ¥27M ↗ |
| Healthcare support | ¥688.31M ↗ | 14.2% | ¥106.81M ↗ |
| Functional Materials Development | ¥297.92M ↗ | 6.1% | −¥28.49M ↗ |
| Biometrics | ¥242.29M ↗ | 5.0% | ¥8.58M ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2024 · fiscal year ended June 2025. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Biometrics
- 生体評価システム
- Healthcare support
- ヘルスケアサポート
- Cosmetics
- 化粧品
- Health supplements
- 健康補助食品
- Functional Materials Development
- 機能性素材開発
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Biometrics
- 生体評価システム
- Healthcare support
- ヘルスケアサポート
- Cosmetics
- 化粧品
- Health supplements
- 健康補助食品
- Functional Materials Development
- 機能性素材開発
- Sales
- 売上高
- Operating profit
- 営業利益
Reported Sales by business over time
Reported Sales by business over time
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Biometrics | ¥553.04M | ¥551.96M | ¥617.06M | ¥236.12M | ¥242.29M |
| Healthcare support | ¥451.47M | ¥548.81M | ¥553M | ¥594.76M | ¥688.31M |
| Cosmetics | ¥4.41B | ¥4.95B | ¥3.94B | ¥1.55B | ¥1.51B |
| Health supplements | ¥2.74B | ¥2.74B | ¥2.49B | ¥2.5B | ¥2.14B |
| Functional Materials Development | ¥806.7M | ¥569.17M | ¥500.6M | ¥317.99M | ¥297.92M |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
Healthcare support
Reported revenue in 2020 ¥451.47M Reported revenue in 2024 ¥688.31M
- growth amount
- +¥236.84M
- growth annualized
- +11.1%
- growth total
- +52.5%
View original filing
Biometrics
Reported profit margin in 2021 +1.2%
Reported profit margin in 2024 +3.5%
- growth margin points
- +2.4
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2024 · fiscal year ended June 2025
The source document may be in Japanese.
Filing ID: S100WQAL
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.